Gastrointestinal
16
2
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms
ADHD, Gut Problems and Synbiotic
GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer
Terraflora Daily Care and Gastrointestinal Health
The Effects of a Postbiotic Supplement on Biomarkers of Gut Health
Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointestinal Outcomes
Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals
Vitamin C With Steroids for Gastrointestinal GVHD
Nutrition, Meal Regularity and Quality of Life in Inflammatory Bowel Disease
Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery
PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers
DIBH Proton Planning
Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic
Gastrointestinal Tolerance of Erythritol-containing Beverages in Young Children
Effects of Citrulline on Gut Functioning During Excercise